SWX:NESN.S News 10 January 2026 - 31 January 2026

France lowered the safety limit for cereulide toxin in infant formula Saturday, prompting more recalls and investigations into two infant deaths. Nestle shares closed at 73.43 Swiss francs Friday, down 0.07%, with trading paused until Monday. Danone recalled Aptamil batches in Germany, while French authorities and Foodwatch pursue legal action. New EU food safety guidance is expected Feb. 2.

Nestle shares fell 0.73% to 74.69 Swiss francs Monday as the Swiss Market Index dropped 1.02% amid broad European losses. The decline followed U.S. tariff threats tied to the Greenland dispute and ongoing fallout from Nestle’s recent infant nutrition recall. The Swiss franc posted its strongest daily gain against the dollar in a month. Nestle’s stock is down about 5.1% for 2026 so far.

Singapore’s Food Agency ordered recalls of two more infant formula products, including Nestlé NAN HA1 SupremePro, after detecting cereulide toxin. Nestlé shares fell 1.7% Friday, closing at 75.24 Swiss francs, near a 52-week low. One mild illness was reported. The company halted sales of the affected batch and offered refunds.

Zurich, January 10, 2026, 21:25 CET — Market closed Nestle (NESN.S) shares ended Friday 1.4% higher at 75.41 Swiss francs, narrowing their weekly drop to around 1.3% after hitting a low of 73.67 earlier in the week. Over the past year, the stock has fluctuated between 69.90 and 91.72. (Investing.com) The Swiss food group is grappling with new regulatory warnings as its infant-formula recall widens—a sensitive area where any quality issue hits hard. Ethiopia’s Food and Drug Authority announced Thursday that Nestlé pulled a batch of NAN Special Pro HA 0–12 (batch 51660742F3). The authority noted the product wasn’t registered